BIOY Performance — GraniteShares YieldBOOST Biotech ETF

Data updated: 2026-09-11

In the 12 months to Jun 2026 the fund took in a net $750K, and assets reached $693K.

BIOY Growth of $100

What $100 invested in GraniteShares YieldBOOST Biotech ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Europe Equity category average over the same months.

PeriodBIOYCategory average
Since data start (Jun 2026 – Jun 2026)$101$97

BIOY Trailing Returns

Total returns to Jun 2026, from SEC N-PORT.

PeriodTotal return
YTD+0.96%

BIOY Annual Returns

Calendar-year total returns of GraniteShares YieldBOOST Biotech ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.

YearTotal return
2026 (Jun–Jun)+0.96%

BIOY Monthly Returns

Monthly total returns as reported on SEC Form N-PORT.

YearJanFebMarAprMayJunJulAugSepOctNovDec
2026—————+1.0%——————

BIOY Risk

Risk measures from monthly returns over Jun 2026 – Jun 2026.

  • Best month: +0.96% (Jun 2026)
  • Worst month: +0.96% (Jun 2026)

BIOY Fund Flows

Monthly money in and out of GraniteShares YieldBOOST Biotech ETF, from SEC Form N-PORT.

  • 12-month net flow: $750K
  • 12-month gross sales (incl. reinvestments): $750K
MonthSalesRedemptionsNet flow
Jun 2026$0$0$0
May 2026$750K$0$750K

BIOY Assets Under Management

Net assets of GraniteShares YieldBOOST Biotech ETF by report date, from SEC N-PORT filings.

Report dateNet assets
2026-06-30$693.21K

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.